The Enterprise Value as of December 2025 (TTM) for Microba Life Sciences Limited (MAP.AX) is 25.07M

According to Microba Life Sciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 25.07M. This represents a change of -50.20% compared to the average of 50.33M of the last 4 quarters.

Microba Life Sciences Limited (MAP.AX) Historical Enterprise Value (quarterly & annually)

How has MAP.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Microba Life Sciences Limited over the last ten years is 60.58M. The current 25.07M Enterprise Value has changed 4.04% with respect to the historical average. Over the past ten years (40 quarters), MAP.AX's Enterprise Value was at its highest in in the December 2020 quarter at 102.92M. The Enterprise Value was at its lowest in in the June 2022 quarter at 25.41M.

Microba Life Sciences Limited (MAP.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Microba Life Sciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Microba Life Sciences Limited (MAP.AX) Average Enterprise Value

How has MAP.AX Enterprise Value performed in the past?

The current Enterprise Value of Microba Life Sciences Limited (MAP.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Microba Life Sciences Limited (MAP.AX) Enterprise Value vs. Peers

How is MAP.AX’s Enterprise Value compared to its peers?

Microba Life Sciences Limited’s Enterprise Value is less than BCAL Diagnostics Limited (34.64M), less than INOVIQ Ltd (31.52M), less than Nova Eye Medical Limited (39.26M), less than Argenica Therapeutics Limited (25.41M), less than Rhythm Biosciences Limited (31.43M), greater than HeraMED Limited (16.75M), less than Emyria Limited (28.58M), less than Next Science Limited (31.11M), less than IDT Australia Limited (33.53M), less than Noxopharm Limited (29.86M),

Build a custom stock screener for Microba Life Sciences Limited (MAP.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Microba Life Sciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Microba Life Sciences Limited (MAP.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Microba Life Sciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.